Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18kDa Translocator Protein (TSPO)

Alessandro Colasanti*, David R Owen, Detelina Grozeva, Eugenii A Rabiner, Paul Matthews, Nick Craddock, Allan H Young

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Citations (Scopus)

Abstract

TSPO mediated transport of cholesterol into the mitochondrion is a necessary step in steroid synthesis. The rs6971 polymorphism in the TSPO gene causes an amino acid substitution (Ala147Thr) within the transmembrane domain where the cholesterol-binding pocket is located, and has been shown to affect the steroidogenic pathway. We report a nominal association between this TSPO polymorphism and the diagnosis of Bipolar Disorder in both the genome-wide dataset of the Wellcome Trust Case-Control Consortium and the Psychiatric Genome-Wide Association Study Consortium Bipolar Disorder group (OR=1.11, p=0.007; OR=1.10, p=0.011, respectively). We propose that the amino acid substitution affects hypothalamic-pituitary-adrenal (HPA) regulation, and hence may predispose to Bipolar Disorder. This supports the hypothesis that HPA dysregulation has a causal role in Bipolar Disorder, and is not just a consequence of the disease.
Original languageEnglish
Pages (from-to)2826-2829
Number of pages4
JournalPsychoneuroendocrinology
Volume38
Issue number11
DOIs
Publication statusPublished - Nov 2013

Keywords

  • Translocator Protein
  • Cortisol
  • HPA
  • Neurosteroids
  • rs6971
  • Genome-wide
  • WTCCC
  • Polymorphism
  • Mitochondria
  • Bipolar Disorder
  • BENZODIAZEPINE-RECEPTOR
  • DEPRESSION
  • BINDING
  • ANXIETY

Fingerprint

Dive into the research topics of 'Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18kDa Translocator Protein (TSPO)'. Together they form a unique fingerprint.

Cite this